BRD4 and Hepatic fibrosis: Knockdown of BRD4 in HSCs attenuated their activation and ECM production, and treatment of fibrotic mice with a BRD4 inhibitor (the BET bromodomain inhibitor JQ1) significantly reduced liver fibrosis.